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Abstract Non-genetic health professionals (NGHPs) have
insufficient knowledge of cancer genetics, express educa-
tional needs and are unprepared to counsel their patients
regarding their genetic test results. So far, it is unclear how
NGHPs perceive their own communication skills. This study
was undertaken to gain insight in their perceptions, attitudes
and knowledge. Two publically accessible databases were
used to invite NGHPs providing cancer genetic services to
complete a questionnaire. The survey assessed: sociodemo-
graphic attributes, experience in ordering hereditary cancer
genetic testing, attitude, knowledge, perception of commu-
nication skills (e.g. information giving, decision-making)
and educational needs. Of all respondents (N = 49, response
rate 11 %), most have a positive view of their own infor-
mation giving (mean = 53.91, range 13–65) and decision
making skills (64–77 % depending on topic). NGHPs feel
responsible for enabling disease and treatment related
behavior (89–91 %). However, 20–30 % reported difficul-
ties managing patients’ emotions and did not see manage-
ment of long-term emotions as their responsibility. Correct
answers on knowledge questions ranged between 41 and
96 %. Higher knowledge was associated with more confi-
dence in NGHPs’ own communication skills (rs = .33,
p = 0.03). Although NGHPs have a positive view of their
communication skills, they perceive more difficulties
managing emotions. The association between less
confidence in communication skills and lower knowledge
level suggests awareness of knowledge gaps affects confi-
dence. NGHPs might benefit from education about manag-
ing client emotions. Further research using observation of
actual counselling consultations is needed to investigate the
skills of this specific group of providers.
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Introduction
Since the early 1990s the possibilities for DNA testing in
cancer have rapidly expanded. Through the combination of
pedigree risk assessment and genetic testing it can be
determined whether a patient’s personal or family history
of cancer has an underlying hereditary cause. Genetic
information about cancer is complex and involves under-
standing risks and inheritance patterns. Many individuals
find such complex information difficult to understand [1,
2]. Explaining genetic information to patients or at-risk
family members is demanding and has traditionally been
carried out by trained medical geneticists and genetic
counselors. Research shows that clinical geneticists and
genetic counselors in general are well trained to provide
genetic information [3]. Hence, they have an important role
in providing the information in an understandable way.
Over the last decade, though, more genetic tests, espe-
cially in the United States, are being ordered by non-genetic
health professionals, such as oncologists, gynecologists, and
primary care providers [4, 5]. The American Society of
Clinical Oncology stressed that the burden on oncologists
becomes greater in fully explaining issues surrounding
cancer risks, including genetic risks. Also, they need to be
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prepared to order genetic tests themselves and to be
responsible for appropriate follow-up care. Therefore, they
need to know of recent genetic advances [6, 7]. This level of
preparedness is not only necessary for oncologists, but also
for other health professionals caring for cancer patients.
The six-function medical communication model of de
Haes and Bensing [8] states that medical communication
should include (1) fostering the relationship, (2) gathering
information, (3) information provision, (4) decision mak-
ing, (5) enabling disease and treatment-related behavior,
and (6) responding to emotions. Communication about
cancer genetics requires all of these communication tasks.
First, proper gathering of information is necessary to
identify someone at high risk. Second, information provi-
sion must be adequate to inform patients and family
members not only with basic information about heredity,
but also about the most adequate treatment and/or pre-
ventive measures. Third, ordering a genetic test asks for
adequate information exchange and (shared) decision-
making. Fourth, motivational communication to enable
patients to follow screening recommendations and undergo
prophylactic surgery, when necessary, is an important task.
Within all communication about genetic testing for cancer,
emotions with regard to the test result and consequences
for the patient and their family should be addressed.
Numerous studies have shown that non-genetic health
professionals have insufficient knowledge of genetics,
express educational needs and are generally unprepared to
counsel their patients regarding genetic test results [9–14].
Also, family history taking [15, 16] and risk communica-
tion [17] are perceived as difficult tasks by non-geneticists.
Inadequate genetic counseling and testing can lead to
negative outcomes in patients and their families [18, 19].
However, not much is known about the attitude towards,
knowledge of and communication skills in discussing and
ordering genetic testing of non-genetic health professionals
(NGHPs) who order genetic tests themselves.
The current study was undertaken to gain insight into the
attitude, knowledge and skills of NGHPs who provide
genetic testing. Investigating the perceptions of non-ge-
netic health professionals about the communication process
will provide insight in their perceived barriers and chal-
lenges to genetic counseling and testing. If deemed nec-
essary this could aid in the development of an intervention
to support and enhance their communication skills.
We also wondered if NGHPs are aware of their
knowledge level. A study by Klitzman et al. [10] showed
that internists who rated (subjectively) their knowledge as
poor, and were uncomfortable ordering testing and coun-
seling patients, still ordered genetic tests. Therefore, in this
study we investigate if NGHPs’ objective knowledge level
is associated with their self-perceived information giving
skills. We hypothesize that if there is an association this
might point to awareness of limitations and thus more
willingness to receive further education.
The primary research questions are:
1. How do NGHPs providing genetic testing perceive
their own communication behavior (attitude, knowl-
edge, skills) in cancer gene testing?
2. What education and/or training have NGHPs received
with regard to communication about cancer gene
testing and what are their needs in this regard?
3. What is the level of knowledge NGHPs have about
cancer gene testing and is it associated with self-
perceived information giving skills?
Materials and methods
Study sample and procedures
The Myriad Genetics Find a Healthcare Provider website
(www.myriadtests.com/finddoc.php) and the National Can-
cer Institute (NCI) Cancer Genetics Services Directory
(www.cancer/gov/cancertopics/genetics/directory) are pub-
lically accessible databases containing contact information
for healthcare providers who have self-identified as cancer
genetic service providers. At the time of this study, Myriad
Genetic Laboratories was the sole provider of genetic testing
for the BRCA1 and BRCA2 genes in the United States. The
Find A Provider section on their website was a mechanism
for patients to identify healthcare professionals in their
communities who provided genetic testing. Listing on the
website was completely voluntary and the list was managed
by Myriad Genetic Laboratories. The database of the NCI
lists professionals who provide services related to cancer
genetics (cancer risk assessment, genetic counseling, genetic
susceptibility testing, and others). Professionals must apply
to be listed in this directory and must meet certain criteria.
Inclusion in the directory does not imply an endorsement by
the National Cancer Institute. Professionals listed are con-
tacted yearly by the NCI through e-mail to verify and/or
update their record information.
For this study, we utilized these databases, to identify
our study population. Study eligibility was as follows: (1)
healthcare professionals self-identified as providing cancer
genetic services with contact information listed on the
Myriad Genetics Find a Healthcare Provider or NCI Cancer
Genetics Services Directory and (2) providers of care in
one of four Midwest states (Ohio, Michigan, Indiana, and
Kentucky). Individuals who met the eligibility criteria were
sent a letter of invitation explaining the aim of the study
along with a paper version of the survey and a return
envelope. The letter of invitation also included a link to an
online version of the survey. A reminder was sent after
342 K. F. L. Douma et al.
123
2 weeks. Completion and return of the study questionnaire
implied consent. Health professionals who completed the
survey and reported they were trained as master-degree
genetic counselors, advanced practice nurses in genetics, or
medical geneticists were excluded from data analysis.
Because of a low response rate we expanded the study to
four more states (Texas, California, New York, and Mas-
sachusetts). The procedure was the same. However, this
time a prize draw for two Amazon gift cards of fifty dollars
and the possibility to receive a report about the results of
the study were added, trying to increase the response rate.




Questionnaire items assessed: (1) Sociodemographic
characteristics, (2) Practice characteristics, (3) Information
giving, (4) Decision-making, (5) Communication about
disease and treatment related behaviors, (6) Managing
emotions, (7) Education and (8) Knowledge. Table 1
shows the details of the measures used.
Data analysis
Descriptive statistics were used to describe the study
sample. Sum scores were calculated for Information giving
Skills perception (see 3b in Table 1) and Objective
knowledge (see 8c in Table 1). The total knowledge score
was calculated by assigning one point for every correct
answer (range 0–9). A mean correct knowledge score was
calculated as the mean number of correct answers on the
knowledge items. In addition, the percentage of correct
answers for each item was analyzed.
We calculated reliability for the three subscales of the
adapted Ideal Patient Autonomy Scale (IPAS) (see
Table 1). Because alpha’s are low, results for individual
items are presented. Pearson’ correlation was calculated for
the association between the total score of Perception of
Information giving skills and the Knowledge score. All
analyses were carried out using IBM SPSS version 20.0. A
p value of .05 (two-sided) was considered significant.
Results
Sample characteristics
In the first mailing (summer 2013) 151 invitations were
sent of which 17 were not delivered due to incorrect
address (returned to sender). In the second mailing (April
2014), we sent out 366 invitations of which 70 returned for
incorrect address. In total, we received 49 questionnaires
(11 % response rate). One filled-in questionnaire was
removed because of many missing values, four others were
removed because they were filled in by participants spe-
cialized in genetic counseling or medical genetics. Table 2
displays the characteristics of the sample.
Information giving
NGHPs reported addressing most relevant topics when
providing cancer genetic counseling. These topics inclu-
ded: benefits and limitations of close cancer surveillance
(95 % always/frequently discuss this), sharing test results
with family members (91 %), benefits and limitations of
prophylactic surgery (89 %) and confidentiality and pri-
vacy (89 %). The possibility of a negative psychological
reaction to genetic testing was least often discussed (73 vs.
89–95 %).
NGHPs positively perceived their own information
giving skills with a mean score 53.91 (SD = 6.8) on a
scale of 13–65. Individual items showed that NGHPs found
it most difficult to inform a patient about a variant test
result: 16 % (strongly) agreed, while 23 % neither agreed
or disagreed. Also, informing minority patients [14 %
(strongly) agreed, 16 % neither agreed nor disagreed] and
lower educated patients [14 % (strongly) agreed, 27 %
neither agreed nor disagreed] was perceived as difficult by
some. In addition, 14 % found it difficult to ensure that
patients understand the genetic test result (27 % neither
agreed nor disagreed) and 14 % found it difficult to inform
a patient about a positive test result (11 % neither agreed
nor disagreed).
Decision-making
On average, NHGPs’ opinion was that patients know best
regarding decisions about genetic testing [mean score is
3.92 (SD = 0.50)] and patients should decide [mean score
is 1.69 (SD = 0.59)]. Furthermore, opinions diverged as to
patients’ right not to pursue genetic testing [mean score is
2.77 (SD = 0.80)]. Table 3 shows the responses to the
individual items of the adapted IPAS.
Figure 1 shows that 7–16 % of NHGPs perceived
communication tasks related to decision-making as diffi-
cult, depending on the task. They experienced most diffi-
culties explaining the consequences of genetic testing for
the patient as well as the family members.
Enabling disease- and treatment related behavior
Ninety-eight percent (n = 43) of NHGPs agreed that it was
their responsibility to discuss preventive behaviors with
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their patients, while only 2 % (n = 1) disagreed. Further-
more, 91 % (n = 40) agreed that it was their responsibility
to remind patients about their screening, 2 % (n = 1)





























































































































































































































































































































































































































































































































































































































































































Surgical oncology 10 23
Medical oncology 6 14
Family medicine 2 5
Gastroenterology 1 2
Other 5 11







51 or more 15 35
Ordered testing forb
Breast and ovarian cancer 42 100
Colorectal cancer 34 81
Endometrial cancer 25 60
Melanoma 16 39
Pancreatic cancer 16 39
Other 5 12




30 or more 13 30
a One missing value
b Missing values are not included in the calculation of percentages.
Three persons had missing values on this question
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Table 3 Adapted Ideal Patient Autonomy Scale







n % n % n %
Scale: Doctors knows best (a = 0.61)
2. It is better that the healthcare provider rather than the patient decides about genetic testing 0 0 3 7 41 93
5. During the conversation, the patient must entrust him/herself to the expertise of the healthcare provider 24 55 13 30 7 16
9. If the healthcare provider and the patient cannot agree on whether or not to undergo genetic testing, the
healthcare provider should make the final decision
0 0 3 7 41 93
10. The patient should, without much information on the consequences, confidently undergo genetic
testing
2 5 4 9 38 86
12. The healthcare provider can presume that the patient knows the consequences of receiving a genetic
test result
1 2 6 14 37 84
Scale: Patient should decide (a = 0.45)
6. The patient must choose between whether to undergo genetic testing or not 39 89 1 2 4 9
11. It would be taking things too far when the healthcare provider would decide for the patient 38 86 3 7 3 7
14. As it concerns the body and life of the patient, the patient should make decisions about genetic testing 41 93 2 5 1 2
Scale: Right to non-participation (a = 0.42)
4. Patients should have the right not to be involved in the decision about genetic testing 13 30 7 16 24 55
8. Patients who become afraid when deciding about genetic testing should be left in peace by the
healthcare provider
14 32 14 32 16 36
13. If a patient chooses not to know anything about their genetic risk, the healthcare provider should
respect this
37 84 2 5 5 11
Items not included in a subscale
1. It is my responsibility to help a patient make a decision about genetic testinga 30 68 7 16 7 16
3. If a healthcare provider and patient properly consult with each other, it does not matter who makes the
final decision about genetic testing
9 20 3 7 32 73
7. Before a patient consents to genetic testing she/he should receive all information on the consequences
of the test result
41 93 1 2 2 5
a Item 1 is self-developed (see Table 1)
Fig. 1 Decision-making
communication tasks
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Ninety-five percent (n = 42) of NHGPs were optimistic
that genetic research will lead to significant improvements
in the treatment of complex traits, while 5 % (n = 2)
neither agreed or disagreed. Seventy-seven percent
(n = 34) agreed that personalized risk information will
motivate people to change their behavior, while 18 %
(n = 8) neither agreed or disagreed and 5 % (n = 2)
disagreed.
Managing emotions
Figure 2 shows that 20–36 % of NHGPs perceived com-
munication tasks related to managing emotions as difficult,
depending on the task. Especially, preparing the patient for
negative emotions and disentangling of emotions related to
genetic testing from emotions related to the disease itself
were perceived as difficult.
Seventy-one percent (n = 31) saw it as their responsi-
bility to the manage emotions patients experience during
genetic counseling, while 18 % (n = 8) neither agreed nor
disagreed and 11 % (n = 5) disagreed with this. Thirty-
nine percent (n = 17) saw it as their responsibility to
manage the long-term emotions ([3 months) patients
experience after a genetic test, while 30 % (n = 13) neither
agreed or disagreed and 32 % (n = 14) disagreed.
Education
Fifty-five percent (n = 24) of respondents received specific
training about how to communicate with patients about
hereditary cancer. This training was received either through
continuing medical education (CME) (36 %), a Myriad-
sponsored course (29 %), fellowship training (9 %), med-
ical school or residency (9 %) or others (such as an
intensive courses on genetics; 15 %).
Participants reported to educate themselves about the
most recent advances in genetic testing with CME (91 %;
n = 40), journal articles (84 %; n = 37), on genetic lab-
oratory sponsored trainings (55 %; n = 24), through col-
leagues (46 %; n = 20) and on the job training (41 %,
n = 18).
Ninety-one percent (n = 40) felt confident about taking
a cancer genetic family history [(strongly) agree], while
9 % (n = 4) neither agreed or disagreed. Thirty-six percent
(n = 16) used web-based tools for taking a family history.
Main reasons for not using these tools are time (n = 6),
unfamiliarity (n = 5), use a paper form (n = 5), prefer
orally discussing family history (n = 3) and other (n = 8).
Seventy-four percent (n = 31) used web-based risk
assessment models. Of those not using web-based risk
assessment tools 79 % (n = 11) would be interested to use
them.
Knowledge
Figure 3 shows that 30–61 % of NHGPs judged their
knowledge on genetics as very good, while 32–64 %
judged it as somewhat good, depending on the specific
topic.
Sixty-eight percent (n = 30) agreed or strongly agreed
that they were confident about their ability to interpret a
variant cancer genetic test result, while 23 % (n = 10)
neither agreed or disagreed and 9 % (n = 4) disagreed.
Ninety-eight percent (n = 43) agreed or strongly agreed
that they are confident about their ability to interpret a
negative cancer genetic test result, while 2 % (n = 1)
neither agreed or disagreed.
The mean knowledge score was 6.5 (SD = 1.7). Table 4
shows that the percentage of participants giving the correct
Fig. 2 Managing emotions
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answer ranged between 41 and 96 %. Only three persons
gave the correct answer to all knowledge questions.
There was a significant positive correlation between
Objective knowledge and Information giving Skills per-
ception, rs = .33, p = 0.03, meaning that participants with
more knowledge had a more positive view on their own
information giving skills.
Discussion
In contrast to known studies showing that providers are
unprepared to counsel their patients [9–14], our study
shows that most non-genetic health professionals ordering
cancer gene testing have a positive attitude towards,
knowledge of and skills in discussing and ordering genetic
testing for cancer.
To be able to interpret these findings we first need to
address the low response rate (11 %) of our study. Our
study may have suffered from response bias, as our
respondents may be those who view this as an important
process whereas those who do not may not have responded.
Also, our data shows that respondents were individuals
with a lot of experience in ordering cancer gene testing
(47 % ordering more than 30 gene tests a year) and half of
them received training regarding communication with
patients about hereditary cancer. These findings suggest an
overrepresentation of experienced and well-trained non-
genetic health professionals. If the low response rate
reflects a lack of interest, this is worrisome. Those who
Fig. 3 Perception of own
oncogenetic knowledge




If a women’s BRCA1 or BRCA2 gene result shows a variant of unknown significance, other affected family members
need to be tested in order to determine the meaning of the result. (false)
41
If a woman’s BRCA1 or BRCA2 gene result reveals a positive test, she should be counseled to have her ovaries surgically
removed after she is done having children. (true)
96
If a father has a mutation in the APC gene (Familial adenomatous polyposis (FAP), his children have a 50 % chance (1 in
2) for carrying this mutation as well. (true)
80
After removal of colon polyps for an FAP diagnosis regular bowel examinations are no longer necessary. (false) 91
A hereditary predisposition to FAP can skip a generation. (false) 52
If a person has colorectal cancer at age 49 and also has a family member with endometrial cancer diagnosed at age
60 years, genetic testing is indicated. (true)
84
A person with uterine cancer at 49 years of age has an indication for genetic counseling. (true) 57
A person with two melanomas has an indication for genetic counseling. (true) 72
If a female is found to have a BRCA mutation and her sister’s BRCA result is negative, the sister is still at increased risk
for developing ovarian cancer. (false)
68
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may not be as comfortable with communicating informed
consent may not be answering and thus it is hard to address
what they specifically need for resources. Furthermore,
while all individuals in the databases identified themselves
as ordering genetic testing we received many returned
envelopes, suggesting that these databases were not as up
to date or representative as may be suggested.
So, how to interpret the positive view of NGHPs of
discussing and ordering genetic tests for cancer? Espe-
cially, as the wealth of available research literature sug-
gest that non-genetic health professionals experience
difficulties in genetic counseling [9, 11, 18, 20–22]. Of
note, medical specialists and primary care physicians (as
in many of the other studies cited) are quite different from
our NGHPs who are part of a database of providers
identifying themselves as providers of genetic testing. Our
respondents, with a high interest in genetic testing, might
indeed have better communication skills or felt the need,
because of social desirability, to at least give this
impression. Future research might use observations of
genetic counseling by non-genetic health professionals
ordering their own genetic testing to investigate the skills
of this specific group.
Our knowledge level seems to be higher than observed
in most other studies where correct answers to knowledge
questions regarding cancer gene testing in non-genetic
health professionals ranged between 13 and 48 % [13, 23–
25] ). In contrast, we also found a study among medical
specialists showing higher levels of knowledge ranging
between 72 and 100 % [26]. It is however hard to compare
these studies as knowledge questions are quite different in
each one of them and different health professionals are
included. It is important to note however, that the high
degree of variability in knowledge scores could raise
concern regarding accuracy of information being given to
some patients. Only three respondents in our study were
able to answer all knowledge questions correctly. Investi-
gation of individual items shows that respondents know
least about consequences for other family members. This
might lead to family members being less well informed if
people get tested through a NGHP. This definitely warrants
further investigation. Also, the fact that more than 30 % of
participants are unsure how to interpret a variance of
unknown significance (VUS) is a reason for concern, as the
number of VUS will increase with the current application
of next generation sequencing (NGS) in the United States.
Although most NGHPs in our study have an overall
positive view, they report more difficulties managing
emotions. In addition, they do not perceive management of
long-term emotions as their responsibility. The majority of
our respondents however are involved in long-term man-
agement of at-risk patients and should be prepared to
address these emotions.
Slightly more than half of our respondents have received
education regarding communication about genetic testing.
The low percentage of NGHPs who received training is a
reason for concern. In the last decennium genetic health
professionals have moved, at least theoretically, from non-
directive counseling to counseling based on principles of
shared decision making [27–29]. However, NGHPs in our
study still seem to have a preference for non-directive
counseling in which patients decides. NGHPs may not be
well informed about the benefits of shared decision making
in genetic counseling.
Our study showed that the higher the knowledge level,
the more confidence non-genetic health professionals
reported in information giving skills. This association
suggests that awareness of knowledge gaps affects health
professionals’ confidence. Would identifying knowledge
gaps in individual NGHPs be a helpful route towards
enhancing quality and consistency of care among providers
performing genetic risk assessment, counselling and test-
ing? Interestingly, Prochniaks’ study suggests that confi-
dence plays an important role in preference of physicians
towards ordering genetic testing themselves or rather refer
to a clinical genetic center [11]. In their study individuals
who had the highest knowledge level were significantly
more likely to have a preference for referral to a cancer
genetics center instead of counseling the patient them-
selves. This suggests that knowing your limitations makes
NGHPs more willing to get further education. In addition,
this could also mean that they value more the contribution
that genetic professionals make to the emotional aspects
that arise during counseling sessions and the genetic pro-
fessional expertise.
Overall, NGHPs who participated in our study have a
positive view on their attitude towards, knowledge of and
skills in discussing and ordering genetic testing. However,
our study raises several concerns about how well-informed
patients and their families will be. Specific attention is
needed for the consequences of genetic testing for family
members and the interpretation of VUS. Continuing med-
ical education should address these issues.
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